Lubomir Arseniev
Hannover, NI, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Point-of-Care Anti-CD19-CAR T-cell Therapy Induces Renal Remission in Refractory Myeloperoxidase-Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis.
Journal: Kidney international reports
Published: April 16, 2025
Automated manufacturing and characterization of clinical grade autologous CD20 CAR T cells for the treatment of patients with stage III/IV melanoma.
Journal: Frontiers in immunology
Published: October 26, 2023
Patient-tailored adoptive immunotherapy with EBV-specific T cells from related and unrelated donors.
Patient-tailored adoptive immunotherapy with EBV-specific T cells from related and unrelated donors.
Journal: The Journal of clinical investigation
Published: July 14, 2022
Extracorporeal immune cell therapy of sepsis: ex vivo results.
Journal: Intensive care medicine experimental
Published: March 19, 2022
GMP-Compliant Manufacturing of TRUCKs: CAR T Cells targeting GD2 and Releasing Inducible IL-18.
Journal: Frontiers in immunology
Published: December 20, 2021
Induced dendritic cells co-expressing GM-CSF/IFN-α/tWT1 priming T and B cells and automated manufacturing to boost GvL.
Journal: Molecular therapy. Methods & clinical development
Published: November 10, 2020
Adenosine stress perfusion cardiac magnetic resonance imaging in patients undergoing intracoronary bone marrow cell transfer after ST-elevation myocardial infarction: the BOOST-2 perfusion substudy.
Journal: Clinical research in cardiology : official journal of the German Cardiac Society
Published: May 24, 2019
Development of Automated Separation, Expansion, and Quality Control Protocols for Clinical-Scale Manufacturing of Primary Human NK Cells and Alpharetroviral Chimeric Antigen Receptor Engineering.
Journal: Human gene therapy methods
Published: April 19, 2019
GMP-compatible manufacturing of three iPS cell lines from human peripheral blood.
Journal: Stem cell research
Published: November 27, 2018
Corrigendum: Triplebody Mediates Increased Anti-Leukemic Reactivity of IL-2 Activated Donor Natural Killer (NK) Cells and Impairs Viability of Their CD33-Expressing NK Subset.
Journal: Frontiers in immunology
Published: September 17, 2018
Functionality and Cell Senescence of CD4/ CD8-Selected CD20 CAR T Cells Manufactured Using the Automated CliniMACS Prodigy® Platform.
Journal: Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie
Published: July 18, 2018
Last Updated: 09/26/2026